Approval · Notice of Compliance 5019 · 1995

PROSCAR: Notice of Compliance 5019

Issued August 22, 1995

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 5019
Date: August 22, 1995
Company: Merck Sharp & Dohme Canada, Division Of Merck Frosst Canada Inc.
Product type: Prescription Pharmaceutical
Submission: Supplement to a New Drug Submission (SNDS), supplement
Submission class: Other
Reason: Revised product monograph
Therapeutic class: 5-alpha-reductase inhibitor

Products in this notice

Brand	DIN	Status today
PROSCAR	Not yet assigned	—

Medicinal ingredients

FINASTERIDE 5 MG per TAB